A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

NCT02367313 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

455

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Vapendavir
DRUG: Vapendavir
DRUG: Placebo

Sponsor

Biota Pharmaceuticals, Inc.